February 6th -7th, 2020

5th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference

San Diego, USA
25+
Speaker
10+
Networking Hours
100
Attendees

Last year, the 4th Edition of this Conference focused on addressing the gaps between early-stage biomarker development and the commercialization stage of biomarkers. Leading industry and academic experts shared their case studies focusing on advancements in the companion diagnostics area. Designed to deliver a forward-looking perspective on the opportunities and challenges impacting market growth for the biomarker industry, the conference will focus on Biomarker Discovery & exploratory Biomarkers and application of biomarkers in Immuno-oncology, neurology and inflammatory diseases.

users

30+ experts from academia and industry will be presenting their current work in Biomarkers, Latest updates on regulatory guidelines and approvals, Cancer biomarker validation for clinical application, Biomarkers and Personalized Medicine, Impact of Big data in translational biomarker research and Future of Companion Diagnostics

users

Opportunity to develop long-lasting business relationships and networking opportunities with researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies, Universities, and Research institutes.

users

Over 20 presentations, round-tables, and panel discussions focused on the key opportunities and challenges in biomarker research, from precision medicine and companion diagnostics through to digital biomarkers and clinical trials.

This two-day event will invite 100+ biomarker discovery professionals, 20+ expert speakers and 15+ solution/technology providers to a unique platform to deliver niche buyer-seller ecosystem in the biomarker Industry.

WHAT TO EXPECT
Who Should Attend

Researchers, Scientists & Clinicians who are active in Biomarker discovery, Translational research, Clinical Biomarker, Imaging Biomarkers & Companion Diagnostics.

Key Highlights

Biomarker Discovery & exploratory Biomarkers, Biomarkers and Personalized Medicine, Impact of Big data in translational biomarker research, Future of Companion Diagnostics

CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
Steven Richards

Steven Richards

Investigator, Biomarker Expert
Novartis

Steven Richards

Investigator, Biomarker Expert
Novartis
Pallavi Sachdev

Pallavi Sachdev

Senior Director, Clinical Pharmacology and Translational Medicine
Eisai

Pallavi Sachdev

Senior Director, Clinical Pharmacology and Translational Medicine
Eisai
Howard Federoff

Howard Federoff

Professor of Neurology
University of California

Howard Federoff

Professor of Neurology
University of California
Speakers
Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets
Steven Richards

Steven Richards

Investigator, Biomarker Expert
Novartis

Steven Richards

Investigator, Biomarker Expert
Novartis
Pallavi Sachdev

Pallavi Sachdev

Senior Director, Clinical Pharmacology and Translational Medicine
Eisai

Pallavi Sachdev

Senior Director, Clinical Pharmacology and Translational Medicine
Eisai
Howard Federoff

Howard Federoff

Professor of Neurology
University of California

Howard Federoff

Professor of Neurology
University of California
Mark Ma

Mark Ma

Executive Director, Bioanalytical & Biomarker Development
Alexion Pharmaceuticals

Mark Ma

Executive Director, Bioanalytical & Biomarker Development
Alexion Pharmaceuticals
Michael Washburn

Michael Washburn

Clinical Biomarker Leader
GSK

Michael Washburn

Clinical Biomarker Leader
GSK
SPONSORS
Gold
example-image

International Drug Development Institute

Silver
example-image

Invivoscribe

example-image

Sengenics

Sponsors & Exhibitors
example-image

Myriad RBM

example-image

Imagia

example-image

Paragon Genomics

example-image

DermTech

PARTNERS
Media Partners
example-image

Technology Networks

LOCATION
San Diego, USA
About the Hotel

PAST EVENT GALLERY